Changes to reporting of serious adverse events.
Maloney
D M
DM
The Deem Corporation, P.O. Box 44069, Omaha, NE 68144, USA.
D003219:Confidentiality; D004274:DNA, Recombinant; D030881:Disclosure; D015316:Genetic Therapy; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation / Q000331:legislation & jurisprudence*; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States
D004274:DNA, Recombinant